Litcius/Paper detail

PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia

Brittany M. Curtiss, Jake VanCampen, Jommel Macaraeg, Garth Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M. Yashar, Yiu Huen Tsang, Wesley Horton, Daniel J. Coleman, Joseph Estabrook, Theresa A. Lusardi, Gordon B. Mills, Brian Druker, Julia E. Maxson, Theodore P. Braun

2022Leukemia16 citationsDOIOpen Access PDF

Topics & Concepts

Myeloid leukemiaCancer researchDemethylaseBiologyProtein kinase BMyeloidLeukemiaPharmacologySignal transductionImmunologyCell biologyEpigeneticsGeneBiochemistryHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsAcute Myeloid Leukemia Research
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia | Litcius